StockClub
ADCTADC Therapeutics S.A.$ --
ADC Therapeutics S.A.

ADC Therapeutics S.A.

ADCT

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
21M USD
YoY -9.5%
Operating Income
-25M USD
YoY +11.3%
Net Income
-33M USD
YoY +14.6%
EPS
-0.21$
YoY +41.7%

Revenue

$20.9M
FY2024 Q2$35.5M
$35.5M
Q2
FY2024 Q3$53.9M
$53.9M
Q3
FY2024 Q4$70.8M
$70.8M
Q4
FY2025 Q1$23M
$23M
Q1
FY2025 Q2$41.9M
$41.9M
Q2
FY2025 Q3$58.3M
$58.3M
Q3
FY2025 Q4$81.4M
$81.4M
Q4
FY2026 Q1$20.9M
$20.9M
Q1
Actual
$-2.2M (-9.5%)

Net Income

$-33M
FY2024 Q2$-83.2M
$-83.2M
Q2
FY2024 Q3$-127.1M
$-127.1M
Q3
FY2024 Q4$-157.8M
$-157.8M
Q4
FY2025 Q1$-38.6M
$-38.6M
Q1
FY2025 Q2$-95.2M
$-95.2M
Q2
FY2025 Q3$-136.2M
$-136.2M
Q3
FY2025 Q4$-142.6M
$-142.6M
Q4
FY2026 Q1$-33M
$-33M
Q1
Actual
+$5.6M (+14.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$0
Est:$1.3M
FY2020MISS
$0
FY2021BEAT
Actual:$33.9M
Est:$33M
FY2021BEAT
$33.9M
FY2022BEAT
Actual:$209.9M
Est:$187.7M
FY2022BEAT
$209.9M
FY2023BEAT
Actual:$69.6M
Est:$66.7M
FY2023BEAT
$69.6M
FY2024MISS
Actual:$70.8M
Est:$72.7M
FY2024MISS
$70.8M
FY2025BEAT
Actual:$81.4M
Est:$80.6M
FY2025BEAT
$81.4M

Analyst Estimates